These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 11788891)

  • 21. Expression of Fas and Fas ligand in cutaneous B-cell lymphomas.
    Zoi-Toli O; Meijer CJ; Oudejans JJ; de Vries E; van Beek P; Willemze R
    J Pathol; 1999 Dec; 189(4):533-8. PubMed ID: 10629554
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Expression of fas ligand on bile ductule epithelium in biliary atresia--a poor prognostic factor.
    Liu C; Chiu JH; Chin T; Wang LS; Li AF; Chow KC; Wei C
    J Pediatr Surg; 2000 Nov; 35(11):1591-6. PubMed ID: 11083430
    [TBL] [Abstract][Full Text] [Related]  

  • 23. c-FLIP expression in colorectal carcinomas: association with Fas/FasL expression and prognostic implications.
    Korkolopoulou P; Saetta AA; Levidou G; Gigelou F; Lazaris A; Thymara I; Scliri M; Bousboukea K; Michalopoulos NV; Apostolikas N; Konstantinidou A; Tzivras M; Patsouris E
    Histopathology; 2007 Aug; 51(2):150-6. PubMed ID: 17559541
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Fas antigen and Fas ligand in bronchoalveolar lavage from silicosis patients.
    Hamzaoui A; Ammar J; Graïri H; Hamzaoui K
    Mediators Inflamm; 2003 Aug; 12(4):209-14. PubMed ID: 14514471
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Role of tumor-associated macrophages (TAM) in advanced gastric carcinoma: the impact on FasL-mediated counterattack.
    Ohno S; Inagawa H; Dhar DK; Fujii T; Ueda S; Tachibana M; Ohno Y; Suzuki N; Inoue M; Soma G; Nagasue N
    Anticancer Res; 2005; 25(1B):463-70. PubMed ID: 15816613
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of Fas ligand by hepatic macrophages in patients with fulminant hepatic failure.
    Mita A; Hashikura Y; Tagawa Y; Nakayama J; Kawakubo M; Miyagawa S
    Am J Gastroenterol; 2005 Nov; 100(11):2551-9. PubMed ID: 16279913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Mechanisms of neutrophil apoptosis in uremia and relevance of the Fas (APO-1, CD95)/Fas ligand system.
    Jaber BL; Perianayagam MC; Balakrishnan VS; King AJ; Pereira BJ
    J Leukoc Biol; 2001 Jun; 69(6):1006-12. PubMed ID: 11404388
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apoptosis dominant in the periinfarct area of human ischaemic stroke--a possible target of antiapoptotic treatments.
    Sairanen T; Karjalainen-Lindsberg ML; Paetau A; Ijäs P; Lindsberg PJ
    Brain; 2006 Jan; 129(Pt 1):189-99. PubMed ID: 16272167
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fas and WAF1 expression in esophageal squamous cell carcinomas.
    Vlachos K; Siafakas N; Karameris A; Athanasas G; Theodoropoulos G; Parassi E; Peros G; Papadopoulos J; Hakim N
    Int Surg; 2006; 91(6):320-5. PubMed ID: 17256429
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
    Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Placental Fas and Fas ligand expression in normal early, term and molar pregnancy.
    Pongcharoen S; Searle RF; Bulmer JN
    Placenta; 2004 Apr; 25(4):321-30. PubMed ID: 15028424
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coelomic cells show apoptosis via Fas/FasL system: a comparative study between healthy human pregnancies and missed miscarriages.
    Kaponis A; Skyrlas A; Zagorianakou N; Georgiou I; Passa V; Paraskevaidis E; Makrydimas G
    Hum Reprod; 2008 May; 23(5):1159-69. PubMed ID: 18316328
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Significance of Fas and Fas ligand in tuberculous lymphadenitis.
    Mustafa T; Mogga SJ; Mfinanga SG; Mørkve O; Sviland L
    Immunology; 2005 Feb; 114(2):255-62. PubMed ID: 15667570
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High molecular weight plasma proteins induce apoptosis and Fas/FasL expression in human proximal tubular cells.
    Morais C; Westhuyzen J; Metharom P; Healy H
    Nephrol Dial Transplant; 2005 Jan; 20(1):50-8. PubMed ID: 15522900
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of Fas and Fas-ligand and analysis of argyrophilic nucleolar organizer regions in squamous cell carcinoma: relationships with tumor stage and grade, and apoptosis.
    Guler N; Uckan S; Celik I; Oznurlu Y; Uckan D
    Int J Oral Maxillofac Surg; 2005 Dec; 34(8):900-6. PubMed ID: 15907374
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Spontaneous apoptosis in advanced esophageal carcinoma: its relation to Fas expression.
    Shibakita M; Tachibana M; Dhar DK; Ohno S; Kubota H; Yoshimura H; Kinugasa S; Masunaga R; Nagasue N
    Clin Cancer Res; 2000 Dec; 6(12):4755-9. PubMed ID: 11156230
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Involvement of the TNF-alpha autocrine-paracrine loop, via NF-kappaB and YY1, in the regulation of tumor cell resistance to Fas-induced apoptosis.
    Huerta-Yepez S; Vega M; Garban H; Bonavida B
    Clin Immunol; 2006 Sep; 120(3):297-309. PubMed ID: 16784892
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Regulation of FasL/Fas in human trophoblasts: possible implications for chorioamnionitis.
    Balkundi DR; Ziegler JA; Watchko JF; Craven C; Trucco M
    Biol Reprod; 2003 Aug; 69(2):718-24. PubMed ID: 12700199
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fas ligand expression in thyroid carcinomas: a potential mechanism of immune evasion.
    Mitsiades N; Poulaki V; Mastorakos G; Tseleni-Balafouta ST; Kotoula V; Koutras DA; Tsokos M
    J Clin Endocrinol Metab; 1999 Aug; 84(8):2924-32. PubMed ID: 10443700
    [TBL] [Abstract][Full Text] [Related]  

  • 40. FR901228 induces tumor regression associated with induction of Fas ligand and activation of Fas signaling in human osteosarcoma cells.
    Imai T; Adachi S; Nishijo K; Ohgushi M; Okada M; Yasumi T; Watanabe K; Nishikomori R; Nakayama T; Yonehara S; Toguchida J; Nakahata T
    Oncogene; 2003 Dec; 22(58):9231-42. PubMed ID: 14647441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.